Abstract: A hydraulic control unit is provided, including a hydraulic control apparatus with a bidirectional pressurization function, where the hydraulic control apparatus includes a second hydraulic chamber and a first hydraulic chamber. The second hydraulic chamber provides a braking force for a first group of wheel cylinders through a first brake line provided with a first control valve. The first hydraulic chamber provides a braking force for a second group of wheel cylinders through a second brake line provided with a second control valve.

Abstract: An end-of-line test method and system are disclosed. The test system includes an upper-level computer, a test device, and a test requirement structured system. The upper-level computer in the test system obtains an initial test formula from the test requirement structured system in response to a test formula download instruction, where the test requirement structured system is configured to generate the initial test formula based on a test item requirement, and the initial test formula includes related information of the test item requirement. Then, the upper-level computer converts the initial test formula into a target test formula in an extensible markup language format. Finally, the upper-level computer controls, based on the target test formula, the test device to test a product to obtain a test result.

Abstract: A heat exchanger based on solution to pinch point in a thermodynamic cycle includes a heat exchange core and a cover plate. The heat exchange core is sealed by the cover plate. Through coordinated structure of first and second flow channels and branch flow channels on alternately stacked cold side and hot side heat exchange plates, the heat exchanger of the present application improves heat exchange efficiency and avoids the adverse effects caused by pinch points. A Brayton cycle system including the heat exchanger is also provided.

Abstract: This application discloses a method and an apparatus for activating an ESC of an intelligent driving vehicle. In this method, an ESC activation probability is obtained after an intelligent driving function of the intelligent driving vehicle is enabled. A pre-exit signal of an ADS and a warning signal are outputted when the ESC activation probability is greater than a preset latch interval. The pre-exit signal indicates the ADS to maintain stability of a traveling status of the intelligent driving vehicle. The warning signal prompts a driver to take over the intelligent driving vehicle. A stability parameter of the intelligent driving vehicle is obtained, where the stability parameter represents a stability characteristic of the traveling status of the intelligent driving vehicle. When the stability parameter meets an ESC activation condition, the ESC of the intelligent driving vehicle is activated.

Abstract: A vehicle control method includes collecting control-related information, determining a road condition scenario based on the control-related information, determining, based on the road condition scenario, a preset braking control parameter set corresponding to the road condition scenario, and performing control configuration based on the determined preset braking control parameter set.

Abstract: A braking method is provided, including: obtaining a braking torque of a wheel; and determining a change amount of an energy regeneration braking torque and a change amount of a friction braking torque based on a change amount of the braking torque of the wheel. The change amount of the braking torque is equal to a sum of the change amount of the energy regeneration braking torque and the change amount of the friction braking torque. According to the method, cooperative control of friction braking and energy regeneration braking in an emergency braking process is implemented, energy regeneration can be fully used to quickly respond to a braking requirement, a control response speed is faster, an energy regeneration rate is higher, and vehicle stability during emergency braking is enhanced. An apparatus for implementing the method, an electronic device, a vehicle, and a storage medium storing the method are further provided.

Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Abstract: Disclosed herein are nucleoside compounds and derivatives thereof, pharmaceutical compositions containing same, and their methods of synthesis. The compounds are useful in treating orthomyxovirus infections, such as influenza infections.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1, R1?, X1, B1, R2, R2?, B2, X2, R3, Z-M-Y, and Y1-M1-Z1 are as defined herein.

Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Abstract: Disclosed are compounds, compositions and methods for treating viral infections, diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1C, B1, R2A, and R2B are defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R, R1B, R1C, R2B, R2C, B1, W, X, Y, Z are defined herein.

Abstract: Embodiments of this application disclose a vehicle control method and device, where the method includes: calculating a longitudinal force interference compensation torque and a lateral force interference compensation torque of a vehicle when a flat tire occurs in the vehicle; calculating a feedback control torque of the vehicle; determining an additional yaw moment based on the longitudinal force interference compensation torque, the feedback control torque, and the lateral force interference compensation torque; and controlling, based on the additional yaw moment, a wheel in which the flat tire occurs.

Abstract: A hydraulic control unit is provided, including a hydraulic control apparatus with a bidirectional pressurization function, where the hydraulic control apparatus includes a second hydraulic chamber and a first hydraulic chamber. The second hydraulic chamber provides a braking force for a first group of wheel cylinders through a first brake line provided with a first control valve. The first hydraulic chamber provides a braking force for a second group of wheel cylinders through a second brake line provided with a second control valve.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I), wherein R1, R1?, X1, B1, R2, R2?, B2, X2, R3, Z-M-Y, and Y1-M1-Z1 are as defined herein.

Abstract: Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

Abstract: Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R, R1B, R1C, R2B, R2C, B1, W, X, Y, Z are defined herein.

Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HBV and/or HDV and/or HIV infection with one or more nucleotide analogs.